Biodollars
Biodollars are a form of financial investment in the biotechnology and pharmaceutical industry. They represent the monetary value of the research and development efforts in these industries, particularly in the development of new drugs and therapies.
Overview[edit | edit source]
Biodollars are often used as a measure of the potential future earnings from a new drug or therapy. They are typically calculated based on the estimated market size for the drug or therapy, the expected price, and the anticipated market share. Biodollars can also include the value of any patents or other intellectual property associated with the drug or therapy.
Calculation[edit | edit source]
The calculation of biodollars is a complex process that involves a number of factors. These include the cost of research and development, the potential market size, the expected price of the drug or therapy, and the anticipated market share. The calculation also takes into account the risk of failure in the development process, as well as the time it takes to bring a drug or therapy to market.
Role in the Biotechnology and Pharmaceutical Industry[edit | edit source]
Biodollars play a crucial role in the biotechnology and pharmaceutical industry. They provide a measure of the potential return on investment for companies in these industries, and can influence decisions about which drugs or therapies to pursue. Biodollars can also be used to attract investment, as they provide a tangible measure of the potential financial return from a new drug or therapy.
Criticisms[edit | edit source]
Despite their widespread use, biodollars have been criticized for a number of reasons. Some argue that they overestimate the potential return on investment, as they do not take into account the high failure rate in drug development. Others argue that they underestimate the cost of research and development, particularly the cost of clinical trials. There are also concerns that the focus on biodollars can lead to a neglect of less profitable but potentially important areas of research.
See also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
